Tumor Ablation Market Analysis And Segment Forecast, 2022

Published: May, 2016 | Pages: 75 | Publisher: Hexa Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global tumor ablation market is expected to grow at a healthy CAGR (compound annual growth rate) over the forecast period (from 2015 to 2022). Improvements in ‘thermal ablation’ technologies help the market prosper. Increasing geriatric populace and ‘cancer’ incidences (that need unique treatments) also contribute market growth.
Moreover, thermal ablation techniques, like irreversible electroporation, laser ablation, High Intensity Focused Ultrasonography (HIFU) etc., are being widely adopted. This also boosts the market incomes. In terms of technical developments, market companies such as ‘SonaCare Medical’ are using ablation technologies for improved care, performance, & accuracy.

The market is classified as per applications, treatments, technologies, and regions. Application segments consist of cancers. These cancers involve the head & neck, ENT, kidneys, liver, breasts, lungs, etc. Liver cancer led the market in 2014 and would notice further expansion in the next seven years. Lungs are projected witness considerable growth owing to inactive lifestyles & air pollution.

Based on treatments, the market is divided by laparoscopic, surgical, and percutaneous. Surgical was the dominant segment in 2015. However, percutaneous treatments should experience huge growth in the near future. This could be credited to demand for minimally invasive surgeries that offer enhanced safety and rapid recovery.

Technologies of the tumor ablation market encompass microwave, radiofrequency, cryoablation, and others. ‘Others’ comprises laser ablation, radioiodine, and High-Intensity Focused Ultrasound (HIFU). Radiofrequency led the technologies market in 2015. Microwave is likely to exhibit significant growth in the next seven years. Its benefits like ‘minimum treatment time’ and ‘superior efficiency’ can add segment expansion.

Geographically, the market is split into the Middle East & Africa, Asia-Pacific (APAC), Latin America, North America, and Europe. North America dominated the market in 2015. This was attributed to its sophisticated medical infrastructure. However, APAC is expected to record the fastest CAGR from 2015 to 2022. Enhanced healthcare infrastructure in China & India will lead to regional expansion.

Leading players in the worldwide tumor ablation market include Boston Scientific Corporation, Galil Medical Inc., Neuwave Medical Inc., and HealthTronics. Product launches, technical innovations, collaborations, & acquisitions are some initiatives taken by these players. For instance, Misonix Inc. acquired Bonescalpel from Aesculap. It assisted ‘ultrasound surgical devices’ in gaining a competitive edge.

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

Chapter 2. Executive Summary
2.1. Tumor Ablation Devices Market– Industry Snapshot and Key Buying Criteria, 2014

Chapter 3. Tumor Ablation Devices Industry Outlook
3.1. Tumor Ablation Devices Market Segmentation
3.2. Tumor Ablation Devices Market Size and Growth Prospects
3.3. Tumor Ablation Devices Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Industry Analysis - Porter's
3.5. Tumor Ablation Devices Market PESTEL Analysis, 2014
3.6. Competitive Landscape

Chapter 4. Tumor Ablation Devices Technology Outlook
4.1. Tumor Ablation Devices Market Share By Technology, 2014 & 2022
4.2. Radiofrequency Ablation Devices
4.2.1. Radiofrequency Ablation Devices Market Estimates and Forecasts, 2015 – 2022
4.3. Microwave Ablation Devices
4.3.1. Tumor Ablation Devices Market Estimates and Forecasts, 2015 – 2022
4.4. Cryoablation Devices
4.4.1. Cryoablation Devices Market Estimates and Forecasts, 2015 – 2022
4.5. Other Ablation Devices
4.5.1. Other Ablation Devices Market Estimates and Forecasts, 2015 – 2022

Chapter 5. Tumor Ablation Devices Treatment Outlook
5.1. Tumor Ablation Devices Market Share By Treatment, 2014 & 2022
5.2. Surgical Ablation
5.2.1. Surgical Ablation Market Estimates and Forecasts, 2015 – 2022
5.3. Laparoscopic Ablation
5.3.1. Laparoscopic Ablation Market Estimates and Forecasts, 2015 – 2022
5.4. Percutaneous Ablation
5.4.1. Percutaneous Ablation Market Estimates and Forecasts, 2015 – 2022

Chapter 6. Tumor Ablation Devices Application Outlook
6.1. Tumor Ablation Devices Market Share By Application, 2014 & 2022
6.2. Liver Cancer
6.2.1. Liver Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.3. Breast Cancer
6.3.1. Breast Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.4. Lung Cancer
6.4.1. Lung Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.5. Prostrate Metastasis
6.5.1. Prostrate Metastasis Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.6. Other Cancer
6.6.1. Other Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022

Chapter 7. Tumor Ablation Devices Regional Outlook
7.1. Tumor Ablation Devices Market Share By Region, 2014 & 2022
7.2. North America
7.2.1. North America Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.3.1.1. Germany Market Estimates and Forecasts
7.3.1.2. UK Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.3.2.1. Germany Market Estimates and Forecasts
7.3.2.2. UK Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.3.3.1. Germany Market Estimates and Forecasts
7.3.3.2. UK Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.5.1.1. Mexico Estimates and Forecasts
7.5.1.2. Brazil Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.5.2.1. Mexico Estimates and Forecasts
7.5.2.2. Brazil Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.5.3.1. Mexico Estimates and Forecasts
7.5.3.2. Brazil Estimates and Forecasts
7.6. MEA
7.6.1. MEA Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.6.1.1. South Africa Estimates and Forecasts
7.6.1.2. Saudi Arabia Estimates and Forecasts
7.6.2. MEA Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.6.2.1. South Africa Estimates and Forecasts
7.6.2.2. Saudi Arabia Estimates and Forecasts
7.6.3. MEA Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.6.3.1. South Africa Estimates and Forecasts
7.6.3.2. Saudi Arabia Estimates and Forecasts

Chapter 8. Competitive Landscape
8.1. Medtronic Plc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Angiodynamics
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Mermaid Medical
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. HealthTronics
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Galil Medical Inc.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. EDAP TMS S.A.
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Boston Scientific Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. SonaCare Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Misonix, Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Neuwave Medical, Inc.
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives

List of Tables

TABLE 1 Tumor ablation market - Industry Summary & Key Buying Criteria
TABLE 2 Tumor ablation market, by technology, 2015 - 2022 (USD million)
TABLE 3 Tumor ablation market, by treatment, 2015 - 2022 (USD million)
TABLE 4 Tumor ablation market, by application, 2015 - 2022 (USD million)
TABLE 5 Tumor ablation market, by region, 2015 - 2022 (USD Million)
TABLE 6 Tumor ablation - Key market driver analysis
TABLE 7 Tumor ablation - Key market restraint analysis
TABLE 8 North America tumor ablation market, by region 2015 - 2022 (USD Million)
TABLE 9 North America tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 10 North America tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 11 North America tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 12 U.S. tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 13 U.S. tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 14 U.S. tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 15 Canada Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 16 Canada Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 17 Canada tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 18 Europe tumor ablation market, by region 2015 - 2022 (USD Million)
TABLE 19 Europe tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 20 Europe tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 21 Europe tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 22 UK Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 23 UK Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 24 UK tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 25 Germany Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 26 Germany Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 27 Germany tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 28 Latin America tumor ablation market, by region 2015 - 2022 (USD Million)
TABLE 29 Latin America tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 30 Latin America tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 31 Latin America tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 32 Brazil Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 33 Brazil Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 34 Brazil tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 35 Mexico Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 36 Mexico Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 37 Mexico tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 38 MEA tumor ablation market, by region 2015 - 2022 (USD Million)
TABLE 39 MEA tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 40 MEA tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 41 MEA tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 42 South Africa Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 43 South Africa Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 44 South Africa tumor ablation market, by application 2015 - 2022 (USD Million)
TABLE 45 Saudi Arabia Tumor ablation market, by technology2015 - 2022 (USD Million)
TABLE 46 Saudi Arabia Tumor ablation market, by treatment 2015 - 2022 (USD Million)
TABLE 47 Saudi Arabia tumor ablation market, by application 2015 - 2022 (USD Million)